Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma

References

• Kim KC, Geng L, Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 2003; 63:7619–7623.
   PubMed Web of Science ®Google Scholar
• Jiang GL, Huang S. The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 2000;15:109–117.
   PubMed Web of Science ®Google Scholar
• Tam W1, Gomez M, Chadburn A, et al. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 2006;107:4090–4100.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006;203:311–317.
   PubMed Web of Science ®Google Scholar
• Cattoretti G1, Angelin-Duclos C, Shaknovich R, et al. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J Pathol 2005;206:76–86.
   PubMed Web of Science ®Google Scholar
• Gyory I, Fejer G, Ghosh N, et al. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 2003;170:3125–3133.
   PubMed Web of Science ®Google Scholar
• Ocaña E, González-García I, Gutiérrez NC, et al. The expression of PRDI-BF1 beta isoform in multiple myeloma plasma cells. Haematologica 2006;91:1579–1580.
   PubMed Web of Science ®Google Scholar
• Nie K, Gomez M, Landgraf P, et al. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells:a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008;173:242–252.
   PubMed Web of Science ®Google Scholar
• Kucuk C, Iqbal J, Hu X, et al. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci USA 2011;108: 20119–20124.
   PubMed Web of Science ®Google Scholar
• Karube K, Nakagawa M, Tsuzuki S, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011;118:3195–3204.
   PubMed Web of Science ®Google Scholar
• Mandelbaum J, Bhagat G, Tang H, et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell 2010;18:568–579.
   PubMed Web of Science ®Google Scholar
• Calado DP, Zhang B, Srinivasan L, et al. Constitutive canonical NF-kappaB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell 2010;18:580–589.
   PubMed Web of Science ®Google Scholar
• Courts C, Montesinos-Rongen M, Brunn A, et al. Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma. J Neuropathol Exp Neurol 2008;67:720–727.
   PubMed Web of Science ®Google Scholar
• Boi M, Zucca E, Inghirami G, et al. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas. Leuk Lymphoma 2014 Oct 7. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Liu YY, Leboeuf C, Shi JY, et al. Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma. Blood 2007;110:339–344.
   PubMed Web of Science ®Google Scholar
• Zhao WL, Liu YY, Zhang QL, et al. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. Blood 2008;111:3867–3871.
   PubMed Web of Science ®Google Scholar
• Zhang YW, Xie HQ, Chen Y, et al. Loss of promoter methylation contributes to the expression of functionally impaired PRDM1beta isoform in diffuse large B-cell lymphoma. Int J Hematol 2010;92:439–444.
   PubMed Web of Science ®Google Scholar
• Nie K, Zhang T, Allawi H, et al. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas. A potential role of the microRNA let-7. Am J Pathol 2010;177:1470–1479.
   PubMed Web of Science ®Google Scholar
• Du Y, Carling T, Fang W, et al. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 2001;61:8094–8099.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Toyota M, Kondo Y, et al. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer. Clin Cancer Res 2007;13:4786–4794.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Kucuk C, Deleeuw RJ, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 2009;23:1139–1151.
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Yang J, Lin J, et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 2009;25:13–20.
   PubMed Web of Science ®Google Scholar
• Shen YL, Jiang YG, Greenlee AR, et al. MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. Biomed Environ Sci 2009;22:14–21.
   PubMed Web of Science ®Google Scholar
• Duan H, Jiang Y, Zhang H, et al. MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro 2010;24:928–935.
   PubMed Web of Science ®Google Scholar
• Yan LX, Huang XF, Shao Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008;14: 2348–2360.
   PubMed Web of Science ®Google Scholar
• Gao W, Shen H, Liu L, et al. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 201;137:557–566.
   Google Scholar
• Chen L, Yan HX, Yang W, et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 2009;50:358–369.
   PubMed Web of Science ®Google Scholar
• Bronisz A, Godlewski J, Wallace JA, et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 2011;14:159–167.
   PubMed Web of Science ®Google Scholar
• Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008;68:6416–6424.
   PubMed Web of Science ®Google Scholar
• Schaar DG, Medina DJ, Moore DF, et al. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol 2009;37:245–255.
   PubMed Web of Science ®Google Scholar
• Hsieh IS, Chang KC, Tsai YT, et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 2013;34: 530–538.
   PubMed Web of Science ®Google Scholar
• Iwagami Y, Eguchi H, Nagano H, et al. miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1. Br J Cancer 2013;109:502–511.
   PubMed Web of Science ®Google Scholar